Abstract Introduction Infection with SARS‐CoV‐2 leads to a spectrum of symptoms. Understanding the basis for severity remains crucial for better management and therapy development. So far, older age, associated‐comorbidities, and IL‐6 have been associated with severity/mortality. Materials and Methodology As a primary step, we analyzed the frequency and functional profile of innate immune cells (NK cells/dendritic cells/monocytes) and adaptive immunity‐driving lymphocytes (B cells/T cells/follicular T helper cells) by flow cytometry. Sixty cases of SARS CoV‐2 infection (25 severe, 35 mild) and ten healthy subjects without SARS CoV‐2 IgG were included. Disease‐duration based analysis of immune profile was explored for early events differentiating the two disease forms. Neutralizing antibody titers were determined by PRNT. Results and Conclusion Disease severity was found to be associated with impaired maturation of mDCs and hyperactivation of NK, follicular T helper cells, and CD8 T cells. Lower IL‐21 receptor expression on memory B cells indicated an imbalance in IL‐21/IL‐21 R ratio. Lower BCMA positive plasmablast cells in severe cases did suggest a probable absence of long‐term humoral immunity. Multivariate analysis revealed a progressive association of PD‐1+CD4 T cells with PRNT 50 titers. Thus, in addition to identifying probable prognostic markers for severity, our study emphasizes the definite need for in‐depth viral antigen‐specific functional analyses in a larger patient cohort and with multiple sampling. Understanding pathogenesis of severity in current SARS‐CoV2 pandemic is of prime importance. Another concern is the recent observations (including ours) of early, higher neutralizing antibody titers in severe disease. India is reporting >80,000/day for several weeks now. Identification of prognostic markers for severity may help identifying “extra‐care‐needed” patients. As a first step, this flow‐cytometry based study was planned to understand (1) differences in immunologic modulations in patients with mild and severe disease (2) if we can identify early events associated with severity (3) prognostic markers for severity (4) association of functionality of immune cells with higher antibody titers in severe disease.
【저자키워드】 disease severity, Innate immune cells, SARS CoV‐2, adaptive immune cells, PRNT50, 【초록키워드】 Monocytes, IgG, Adaptive immunity, pandemic, therapy, Pathogenesis, Lymphocytes, adaptive, T cells, severity, India, Infection, B cells, memory B cells, NK cells, Immune profile, Prognostic markers, Symptoms, dendritic cells, mDCs, flow cytometry, SARS‐CoV‐2, lymphocyte, Humoral immunity, T cell, management, Patient, Older age, Antibody titer, severe cases, understanding, Prognostic marker, Mild, immune cells, Innate immune cells, receptor, Spectrum, disease, expression, patients, CD8 T cells, memory B cell, PRNT, Neutralizing antibody titer, T helper cells, association, Multivariate analysis, Frequency, Analysis, Immune cell, SARS‑CoV2, severe disease, identification, determined by, observation, Imbalance, modulation, maturation, neutralizing antibody titers, help, Severe case, material, IL‐6, positive, Hyperactivation, patient cohort, Lower, forms, Cell, event, Result, analyzed, identify, indicated, addition, functional, absence, healthy subject, follicular, innate immune cell, mDC, 【제목키워드】 severity, Prognostic marker, Mild, Immune cell, identify, infected patient, subset, presenting, severe symptom,